Press Release CORE Biomedicine Signs Exclusive Licensing Agreement with Eisai for Precision Oncology Programs Jul 28
Press Release CORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics Jul 28